Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized Treatment for MDD with Atypical Features
NCT04209166Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Aug 2019
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of quetiapine in major depressive disorder (MDD), sponsored by Shanghai Mental Health Center. Status: unknown.
02
Drugs
quetiapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04209166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04209166.